A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia
Clinical trial NCT02477020 · COMPLETED
Trial details
- NCT number
- NCT02477020
- Sponsor
- Takeda
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2016-07-13
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.